These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33675252)

  • 21. ASTHMA IN A PATIENT WITH COVID-19: DOES IT PROTECT OR INCREASE THE RISKS?
    Kochuieva MN; Psarova VH; Shklyar SP; Oparin AA
    Wiad Lek; 2021; 74(5):1245-1249. PubMed ID: 34090299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric asthma and COVID-19: The known, the unknown, and the controversial.
    Abrams EM; Sinha I; Fernandes RM; Hawcutt DB
    Pediatr Pulmonol; 2020 Dec; 55(12):3573-3578. PubMed ID: 33058493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronavirus SARS-Cov-2 and arterial hypertension - facts and myths.
    Surma S; Romańczyk M; Łabuzek K
    Pol Merkur Lekarski; 2020 Jun; 48(285):195-198. PubMed ID: 32564046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of comorbid asthma in COVID-19 patients.
    Butler MW; O'Reilly A; Dunican EM; Mallon P; Feeney ER; Keane MP; McCarthy C
    J Allergy Clin Immunol; 2020 Aug; 146(2):334-335. PubMed ID: 32553599
    [No Abstract]   [Full Text] [Related]  

  • 25. Risk factors for bronchiolitis and asthma, and COVID-19 symptoms in young children.
    Eigenmann P
    Pediatr Allergy Immunol; 2021 Feb; 32(2):215-218. PubMed ID: 33522012
    [No Abstract]   [Full Text] [Related]  

  • 26. Asthma and severe acute respiratory syndrome coronavirus 2019: current evidence and knowledge gaps.
    Assaf SM; Tarasevych SP; Diamant Z; Hanania NA
    Curr Opin Pulm Med; 2021 Jan; 27(1):45-53. PubMed ID: 33065601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of endopeptidases, involved in SARS-CoV-2 infection, with microbial aggravation in sputum of severe asthma.
    Abdel-Aziz MI; Kermani NZ; Neerincx AH; Vijverberg SJH; Guo Y; Howarth P; Dahlen SE; Djukanovic R; Sterk PJ; Kraneveld AD; Maitland-van der Zee AH; Chung KF; Adcock IM;
    Allergy; 2021 Jun; 76(6):1917-1921. PubMed ID: 33411967
    [No Abstract]   [Full Text] [Related]  

  • 28. Asthma and COVID-19.
    Singh PN
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2939. PubMed ID: 34246441
    [No Abstract]   [Full Text] [Related]  

  • 29. Asthma and COVID: What Are the Important Questions?
    Panettieri RA; Carson J; Horton D; Barrett E; Roy J; Radbel J
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2487-2488. PubMed ID: 32585410
    [No Abstract]   [Full Text] [Related]  

  • 30. CCR5Δ32 mutations do not determine COVID-19 disease course.
    Bernas SN; Baldauf H; Wendler S; Heidenreich F; Lange V; Hofmann JA; Sauter J; Schmidt AH; Schetelig J
    Int J Infect Dis; 2021 Apr; 105():653-655. PubMed ID: 33667698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.
    Albini A; Di Guardo G; Noonan DM; Lombardo M
    Intern Emerg Med; 2020 Aug; 15(5):759-766. PubMed ID: 32430651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reply to "Does asthma affect outcomes of patients with COVID-19 infections?".
    Mahdavinia M; Codispoti CD
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):594-595. PubMed ID: 32992042
    [No Abstract]   [Full Text] [Related]  

  • 33. COVID-19, asthma, and return to school.
    Abrams EM; McGill G; Bhopal SS; Sinha I; Fernandes RM
    Lancet Respir Med; 2020 Sep; 8(9):847-849. PubMed ID: 32771080
    [No Abstract]   [Full Text] [Related]  

  • 34. General health status of children with asthma during the COVID-19 pandemic.
    Hepkaya E; Kilinc AA; Cebi MN; Koyuncu Z; Cokugras H
    Pediatr Int; 2021 Mar; 63(3):331-337. PubMed ID: 32881185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the COVID-19 pandemic in children with allergic asthma.
    Ruano FJ; Somoza Álvarez ML; Haroun-Díaz E; Vázquez de la Torre M; López González P; Prieto-Moreno A; Torres Rojas I; Cervera García MD; Pérez Alzate D; Blanca-López N; Canto Díez G
    J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3172-3174.e1. PubMed ID: 32730834
    [No Abstract]   [Full Text] [Related]  

  • 36. Does asthma affect outcomes of patients with COVID-19 infections?
    Kalemci S; Sarıhan A; Zeybek A
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):594. PubMed ID: 32992043
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact of COVID-19 on Patient-Initiated Discontinuation of Omalizumab in Two Academic Hospital Clinics at the University of Toronto.
    Seung Kim JH; Georgakopoulos JR; Yeung J
    J Cutan Med Surg; 2020; 24(5):534-535. PubMed ID: 33023343
    [No Abstract]   [Full Text] [Related]  

  • 38. Asthma may not be a risk factor for severe COVID-19 in children.
    Amat F; Delaisi B; Labbé JP; Leonardi J; Houdouin V
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2478-2479. PubMed ID: 33852880
    [No Abstract]   [Full Text] [Related]  

  • 39. Allergy and asthma in children and adolescents during the COVID outbreak: What we know and how we could prevent allergy and asthma flares.
    Licari A; Votto M; Brambilla I; Castagnoli R; Piccotti E; Olcese R; Tosca MA; Ciprandi G; Marseglia GL
    Allergy; 2020 Sep; 75(9):2402-2405. PubMed ID: 32418233
    [No Abstract]   [Full Text] [Related]  

  • 40. Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?
    Heffler E; Detoraki A; Contoli M; Papi A; Paoletti G; Malipiero G; Brussino L; Crimi C; Morrone D; Padovani M; Guida G; Gerli AG; Centanni S; Senna G; Paggiaro P; Blasi F; Canonica GW;
    Allergy; 2021 Mar; 76(3):961-962. PubMed ID: 33675253
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.